Breaking News

Crystal Pharmatech’s CDMO Business Unit Receives China Drug Product Manufacturing License

The license marks an important milestone in expanding and upgrading the company's service capabilities.

Crystal Formulation Services, a subsidiary of Crystal Pharmatech, was granted the “Drug Manufacturing License” (C Certificate) by the Jiangsu Medical Products Administration, a branch of the Chinese National Medical Products Administration (NMPA). This achievement highlights Crystal Formulation Services as a leading professional formulation CDMO by confirming that their quality system, GMP facilities, and software systems all meet the rigorous requirements of the Chinese NMPA’s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters